vid - They do not have to sell fairly soon. They have cash to fund them through next year , an approved drug, and another in clinical development. Forget what you and I want or hope will happen. The most likely scenario is they regroup - perhaps partner 113 or Iclusig. If you were an employee and not a shareholder that is what you would expect them to do.
Market Data 
Markets 
AI
